Skin, Decoded
← Contents

Straight answer

What does a filaggrin variant mean for your skin?

Answered in plain English, with sources

It means your skin barrier is probably a bit less robust, and your odds of eczema are higher than average. It does not mean you will get eczema. Most people who carry one never do.

Filaggrin is one of the few skin genetics stories that is genuinely well understood. The gene is FLG. Certain variants switch it off. Less filaggrin means a weaker barrier, and a weaker barrier is a real risk factor for eczema. That much is solid, replicated, and taught in dermatology.

What gets lost in retelling is the size of the effect and what it does not say. A risk factor is not a diagnosis, and “higher than average” can still mean “unlikely”.

What filaggrin does

In the outer layer of skin, filaggrin binds keratin filaments into tight bundles, then breaks down into small molecules that hold water and keep the skin surface acidic. Those breakdown products are a large part of what people mean by “natural moisturising factor”. Lose filaggrin and you lose structure, hydration and some of the chemical defence that keeps the barrier intact.

The mechanism in one line

Less filaggrin → weaker barrier → more water loss and easier entry for irritants and allergens → more inflammation in skin that is already prone to it.

How common it is, and why ancestry matters

CarriersRoughly 8–10% of people of European ancestry carry one FLG null variant
Two copiesMuch higher risk, and the basis of ichthyosis vulgaris
AncestryThe classic variants are common in Europe and rare elsewhere; different populations have different loss-of-function changes

This is the part consumer tests routinely get wrong. A test panel built on European variants will report “no filaggrin variant” for someone from a population where the relevant variants were never on the chip. Absence of a result is not absence of a variant.

What it means in practice

  • Your baseline risk of eczema is higher. If you already have eczema, it makes the barrier explanation more likely.
  • It says nothing about which product fixes it. There is no filaggrin cream that restores the protein.
  • It does make the boring advice matter more: fewer harsh surfactants, consistent moisturising, and treating flare-ups early rather than waiting.
  • It does not change what a dermatologist would do. Management is still driven by your skin, not your genotype.

Genotype has one genuinely useful role: it explains why a barrier problem exists, which can make people take barrier care seriously instead of hunting for a more exciting cause. That is a psychological benefit, not a pharmacological one.

What it does not mean

“I have the variant, so I will get eczema.”

No.

Most carriers never develop atopic dermatitis. The variant shifts probability; it does not set fate. Environment, other genes and what your skin is exposed to all move the outcome.

“Two copies means my children will definitely have it.”

No.

Two copies raises risk substantially — and still leaves plenty of carriers unaffected. Inheritance is probabilistic, not deterministic.

The bottom line

What to take away

A filaggrin variant is a well-established risk factor for a leaky skin barrier, not a diagnosis and not a sentence. It justifies barrier-friendly habits and a lower threshold for seeing a dermatologist. It does not justify buying a “gene-targeted” cream, because none exists that replaces the protein.

Read next

Sources

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisPalmer C.N.A. et al., Nature Genetics 38, 441–446 (2006)

The founding filaggrin–eczema association.

Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skinStege H. et al., PNAS 97(4), 1790–1795 (2000)

Liposomal photolyase plus photoreactivating light reduced UVB-induced DNA dimers in human skin.

Not medical advice. General education only. If you have a skin concern, see a dermatologist. AlphaGenome and AlphaGenome 2 are research tools, not validated for clinical use.